Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 10:406:34-40.
doi: 10.1016/j.carres.2015.01.004. Epub 2015 Jan 19.

'Click chemistry' synthesis of 1-(α-D-mannopyranosyl)-1,2,3-triazoles for inhibition of α-mannosidases

Monika Poláková  1 , Rhiannon Stanton  2 , Iain B H Wilson  2 , Ivana Holková  3 , Sergej Šesták  4 , Eva Machová  4 , Zuzana Jandová  5 , Juraj Kóňa  4
Affiliations

'Click chemistry' synthesis of 1-(α-D-mannopyranosyl)-1,2,3-triazoles for inhibition of α-mannosidases

Monika Poláková et al. Carbohydr Res. .

Abstract

Three new triazole conjugates derived from d-mannose were synthesized and assayed in in vitro assays to investigate their ability to inhibit α-mannosidase enzymes from the glycoside hydrolase (GH) families 38 and 47. The triazole conjugates were more selective for a GH47 α-mannosidase (Aspergillus saitoi α1,2-mannosidase), showing inhibition at the micromolar level (IC50 values of 50-250 μM), and less potent towards GH38 mannosidases (IC50 values in the range of 0.5-6 mM towards jack bean α-mannosidase or Drosophila melanogaster lysosomal and Golgi α-mannosidases). The highest selectivity ratio [IC50(GH38)/IC50(GH47)] of 100 was exhibited by the phenyltriazole conjugate. To understand structure-activity properties of synthesized compounds, 3-D complexes of inhibitors with α-mannosidases were built using molecular docking calculations.

Keywords: 1-(d-Mannopyranosyl)-1,2,3-triazole; Click reaction; Glycoside hydrolase; Molecular docking; α-Mannosidase inhibitor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) A superposition of the compounds 6 (with carbons in green), 7 (in yellow) and 8 (in magenta) docked in the active site of hERManI (PDB ID: 1FO3); (B) Selected interactions between the inhibitor 6 (in red) and hERManI.
Figure 2
Figure 2
A superposition of the compound 7 with an analogous mannoside 9 with the triazole group substituted by the sulfone group in the active site of dGMII (PDB ID: 3BLB). For a comparison, interactions of triazole and sulfone group with active-site amino acid residues of dGMII (Asp341, Tyr269 and Arg228) are visualized.
Figure 3
Figure 3
The best five docking poses for the triazole 7 found for dGMII and bLM. In both cases the benzyl moiety of the inhibitor was found in two binding sites (B1 and B2). A binding site (B3) which may be responsible for a selective binding of the inhibitor was empty. This may explain the lack of selectivity observed for the triazole mannosides.
Scheme 1
Scheme 1
Reagents and conditions. (a) 2a, 2b or 2c, CuSO4, sodium ascorbate, DMF:H2O 3:1, 3 h, rt, 86-91%; (b) K2CO3, MeOH, 30 min, rt, 87-93%.
See this image and copyright information in PMC

References

    1. Tornoe CW, Meldal M. Chem. Rev. 2008;108:2952–3015. - PubMed
    1. Kolb HC, Sharpless KB. Drug Discov. Today. 2003;8:1128–1137. - PubMed
    1. Moses JE, Moorhouse AD. Chem. Soc. Rev. 2007;36:1249–1262. - PubMed
    1. Lutz JF, Zarafshani Z. Adv. Drug Deliver. Rev. 2008;60:958–970. - PubMed
    1. Baskin JM, Bertozzi CR. Qsar Comb. Sci. 2007;26:1211–1219.

Publication types

LinkOut - more resources